Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

BACKGROUND: Chronic kidney disease (CKD) is a risk factor for end-stage renal failure and cardiovascular disease, and a strategy to counteract CKD must be established. CKD caused by immunological abnormalities is treated by steroids, frequently resulting in steroid diabetes. Although insulin is the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ohashi, Naro, Tsuji, Naoko, Naito, Yoshitaka, Iwakura, Takamasa, Isobe, Shinsuke, Ono, Masafumi, Fujikura, Tomoyuki, Tsuji, Takayuki, Sakao, Yukitoshi, Yasuda, Hideo, Kato, Akihiko, Fujigaki, Yoshihide
Formato: Artigo
Idioma:Inglês
Publicado: International Scientific Literature, Inc. 2014
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989946/
https://ncbi.nlm.nih.gov/pubmed/24717767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.889872
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares